EQS-Adhoc

Noratis AG: Noratis AG decides on a rights issue for existing shareholders and plans cash capital increase afterwards as well as adjustment of the corporate strategy - Seite 3

In view of the investment agreement with Merz Real Estate GmbH & Co. KG a further cash capital increase (Barkapitalerhöhung) with a volume of EUR 2 million (gross) is to be carried out immediately after the entry of the rights issue into the commercial register (Handelsregister), in which only Merz Real Estate GmbH & Co. KG shall be authorized to subscribe to the new shares and the subscription rights of the other shareholders shall be excluded in accordance with the principles of the simplified exclusion of subscription rights pursuant to Section 186 (3) sent. 4 of the German Stock Corporation Act (Aktiengesetz).

B. Metzler seel. Sohn & Co. Aktiengesellschaft will support the two capital increases and act as the subscription agent (Bezugsstelle) for the rights issue.

In view of the changed market environment for real estate transactions, Noratis will now also focus more strongly on property portfolio management, including corresponding cost savings and adjustments to the corporate strategy.

 

Investor & Public Relations Contact:

edicto GmbH
Dr Sönke Knop
069 905 505 51
[e-mail]
Eschersheimer Landstraße 42
60322 Frankfurt am Main

Important notes:

This announcement does not constitute an offer to sell or a solicitation to buy or subscribe to securities in any jurisdiction or a prospectus within the meaning of Regulation (EU) 2017/1129, as amended (“Prospectus Regulation”). A public offer is made exclusively through and on the basis of a securities information sheet to be published after approval by the German Federal Financial Supervisory Authority (BaFin). The securities information sheet contains the information for investors required by law. The securities information sheet will be accessible on 15 November 2023 on the website of the Noratis AG (www.noratis.de) in the section “Investor Relations” free of charge. The subscription offer is expected to be published on 17 November 2023.